GENOMIC VALLEY BIOTECH LIMITED (GVBL.BO)
INR 79.0
(-2.71%)
INR 79.0
(-2.71%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.65 Million INR | -93.94% |
| 2022 | 27.22 Million INR | 3758.23% |
| 2021 | 705.64 Thousand INR | -66.09% |
| 2020 | 2.08 Million INR | -75.42% |
| 2019 | 8.46 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 1.55 Million INR | 0.0% |
| 2023 Q3 | 390 Thousand INR | -42.24% |
| 2023 Q1 | 585.5 Thousand INR | -94.12% |
| 2023 Q4 | - INR | -100.0% |
| 2023 FY | 1.65 Million INR | -93.94% |
| 2023 Q2 | 675.25 Thousand INR | 15.33% |
| 2022 Q2 | 205 Thousand INR | 0.0% |
| 2022 FY | 27.22 Million INR | 3758.23% |
| 2022 Q3 | 6.72 Million INR | 3178.75% |
| 2022 Q4 | 9.96 Million INR | 48.19% |
| 2021 FY | 705.64 Thousand INR | -66.09% |
| 2020 FY | 2.08 Million INR | -75.42% |
| 2019 FY | 8.46 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 31.27 Million INR | 94.721% |
| Biocon Limited | 147.55 Billion INR | 99.999% |
| Blue Jet Healthcare Limited | 7.11 Billion INR | 99.977% |
| Concord Biotech Limited | 10.16 Billion INR | 99.984% |
| Dishman Carbogen Amcis Limited | 26.15 Billion INR | 99.994% |
| FERMENTA BIOTECH LIMITED | 3.35 Billion INR | 99.951% |
| Lyka Labs Limited | 1.05 Billion INR | 99.843% |
| Panacea Biotec Limited | 5.51 Billion INR | 99.97% |
| SAMSRITA LABS LIMITED | - INR | -Infinity% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 3.05 Billion INR | 99.946% |
| Supriya Lifescience Limited | 5.7 Billion INR | 99.971% |
| Syngene International Limited | 34.88 Billion INR | 99.995% |
| TAKE Solutions Limited | 656.08 Million INR | 99.748% |
| Titan Biotech Limited | 1.64 Billion INR | 99.899% |
| Transgene Biotek Limited | 2.34 Million INR | 29.725% |
| Vanta Bioscience Limited | 97.22 Million INR | 98.302% |